The HepQuant-SHUNT™ test has been used in clinical trials with pharmaceutical companies and research institutions under FDA guidelines over the last decade – this experience includes 11 companies and 7 academic or research institutions. Currently we have 9 ongoing trials with leading pharmaceutical companies and 3 with leading research institutions. We have over 60 active clinical sites performing the test with over 100 sites projected to do the test. In total, past, current, and future commitments encompass over 3100 tests in over 1500 subjects. This year, despite COVID19, HepQuant has seen an uptick in implementation in drug development.